Program & Downloads
Click here to download the entire book (139KB) – To navigate in the pages, please use the search tool or the bookmarks.
Click here to view the speakers list
CONGRESS 2009
- 8:45 Introduction : Viral Hepatitis in 2009 - Patrick MARCELLIN (France)
-
9:00 – 10:30
Chairs :
Teresa WRIGHT (USA) Nezam AFDHAL (USA)
- 9:00 How to use the virological tools for the optimal follow up of chronic hepatitis C - Jean-Michel PAWLOTSKY (France) Download
- 9:20 What are the co-morbidities influencing the management of patients and the response to therapy ? - Alfredo ALBERTI (Italy)
- 9:40 Non invasive fibrosis markers and/or liver biopsy ? - Pierre BEDOSSA (France) Download
- 10:00 Round table - All speakers
- 10:30 - 11:00 Coffee break
-
11:00 – 12:30
Optimizing therapy in real life illustrated with clinical cases
Chairs :
Peter FERENCI (Austria) Graham FOSTER (UK)
- 11:00 Optimizing therapy in real life illustrated with clinical cases Optimal therapy in genotype 1 patients - Stefan ZEUZEM (Germany) Download
- 11:20 Optimal therapy in genotype 2 and 3 patients - Antonio CRAXI (Italy) Download
- 11:40 Optimal therapy in genotype 4 patients - Sanaa KAMAL (Egypt) Download
- 12:00 Round table - All speakers
-
12:30 – 14:00 Luncheons Room 1
The burden of hepatitis C in Europe. Epidemiology, actions to increase awareness and access to care
Chair: Daniel LAVANCHY (Switzerland)
Room 3
Clinical Management of hepatitis C in an environment with limited access to treatment
Chair: Eugene SCHIFF (USA)
Speaker:
Andrzej HORBAN (Poland) Download
Room 5
Management of HIV-HCV co-infected patients
Chair: Stanislas POL (France)
Speaker:
Juergen ROCKSTROH (Germany) Download
Room 6
French Luncheon : comment prendre en charge les patients atteints d’hépatite C avec les médicaments disponibles dans mon pays.
Chair: Daniel DHUMEAUX (France)
Speakers:
Christoph SARRAZIN (Germany) Download
Abdellah ESSAID EL FEYDI (Maroc) Download
Saadi BERKANE (Algeria) Download
-
14:00 – 16:00
Chairs :
Masao OMATA (Japan) Marc BOURLIERE (France)
- 14:00 Retreatment : who and how ? - Jenny HEATHCOTE (Canada)
- 14:15 New drugs : Enzyme inhibitors - Tarik ASSELAH (France) Download
- 14:45 What future for ribavirin ? - Mitchell SHIFFMAN (USA) Download
- 15:00 Round table - All speakers
- 15:30 Clinical case - Eugene SCHIFF (USA)
- 16:00 - 16:30 Coffee break
- 16:30 – 18:00 State of the Art Lecture - Patrick MARCELLIN (France)
- 16:30 The global burden of hepatitis C - Daniel LAVANCHY (Switzerland) Download
- 16:50 1989 -2009 : HCV twenty years after From B to non B to C : the historical evolution of hepatitises viruses - Harvey ALTER (USA)
- 17:10 The HCV discovery - Michael HOUGHTON (USA) Download
- 17:30 The history of the "natural history" of hepatitis C - Leonard SEEFF (USA)
- 18:00 Awards ceremonyw
- 20:00 Congress Dinner
-
8:30 - 10:00
Chairs :
Michael MANNS (Germany) Feruccio BONINO (Italy)
- 08:30 Natural history of HBV and long-term outcome under treatment - Yun-Fan LIAW (Taiwan)
- 08:50 How to prevent, diagnose and overcome resistance under nucleos(t)ide analogs ? - Fabien ZOULIM (France) Download
- 09:10 New endpoints. Back to the future with Australia Antigen ? - Maurizia BRUNETTO (Italy) Download
- 09:30 Round table - All speakers
- 10:00 - 10:30 Coffee Break
-
10:30 - 11:30
HBeAg-positive chronic hepatitis B
Chairs :
Geoffrey DUSHEIKO (UK) Stanislas POL (France)
- 10:45 Why do I treat my patients with pegylated interferon ? - George LAU (Hong Kong) Download
- 11:00 Round table - All Speakers
-
11:30 - 12:30
HBeAg negative chronic hepatitis B
Chairs :
Stephanos HADZIYANNIS (Greece) Jean-Pierre ZARSKI (France)
- 11:30 Why do I treat my patients with nucleos(t)ide analogs ? - Pietro LAMPERTICO (Italy) Download
- 11:45 Why do I treat my patients with pegylated interferon ? - Robert PERRILLO (USA) Download
- 12:00 Round table - All speakers
-
12:30 - 14:00 Luncheons Room 1
Hepatitis B: predictors and endpoints revisited?
Chair: Feruccio BONINO (Italy)
Speaker:
Rami MOUCARI (United Arab Emirates) Download
Room 2
How to optimize the management of my HBeAg negative patient?
Chair: Jean-Pierre ZARSKI (France)
Speaker:
Pietro LAMPERTICO (Italy) Download
Room 3
End stage HBV-related liver disease: what’s left to do?
Chair: Massimo COLOMBO (Italy)
Speaker:
François DURAND (France) Download
Room 4
How to manage patients with hepatitis B with limited access to care ?
Chair: Robert PERRILLO (USA)
Room 5
French Luncheon : comment prendre en charge les patients atteints d’hépatite B avec les médicaments disponibles dans mon pays
Chair: Christian TREPO (France)
- 14:00 EASL clinical pratice guidelines : management of chronic hepatitis B - Patrick MARCELLIN (France)
-
14:15 - 15:15
Chairs :
Cihan YURDAYDIN (Turkey) Didier SAMUEL (France)
- 14:15 Hepatitis B and pregnancy : an underestimated issue - Maureen JONAS (USA) Download
- 14:35 Hepatitis D: the come back ? - Mario RIZZETTO (Italy) Download
- 14:55 Clinical case - Marion PETERS (USA) Download
-
15:15 - 16:15
Hepatocellular carcinoma
Chairs :
Adrian DI BISCEGLIE (USA) Rafael ESTEBAN (Spain)
- 15:15 Screening and diagnosis of hepatocellular carcinoma - Massimo COLOMBO (Italy) Download
- 15:35 New drugs for hepatocellular carcinoma - Jordi BRUIX (Spain) Download
- 15:55 Round table
- 16:15 Conclusion and perspectives - Patrick MARCELLIN (France) Download